Haematological cancer genetics
The ultimate goal of the team is to help develop treatments that can improve the survival and quality of life of cancer sufferers.
- Identification of genetic vulnerabilities in acute myeloid leukaemia
Professor George S Vassiliou, FRCPath, MRCP, PhD
Group Leader and Honorary Consultant Haematologist
George Vassiliou is a Cancer Research UK Senior Fellow and an Honorary Consultant Haematologist at Cambridge University Hospitals. He heads the Haematological Cancer Genetics Group at the Sanger Institute and is member of Faculty at the Cambridge Stem Cell Institute. His team studies blood cancers with a particular focus on myeloid leukaemias their pathogenesis, clonal evolution and the development of new anti-leukaemia treatments. Additionally, they develop and apply novel molecular methodologies for the diagnosis, classification and treatment of haematological cancers.
Cancer Genome Project
Cancer Genetics & Genomics
Throughout life, the genome within cells of the human body is exposed to DNA damage and suffers mistakes in replication. These ...
High throughput gene editing
The High Throughput Gene Editing team helped to deliver the gene editing requirements of the Institute's faculty and research